Moderna (MRNA) PT Raised to $115 at BofA Securities
Tweet
Share
E-mail
Get Alerts MRNA Hot Sheet
Price: $62.86 -2.48%
Rating Summary:
5 Buy, 21 Hold, 4 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 12 | New: 26
Rating Summary:
5 Buy, 21 Hold, 4 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 12 | New: 26
Join SI Premium – FREE
BofA Securities analyst Geoff Meacham raised the price target on Moderna (NASDAQ: MRNA) to $115.00 (from $110.00) while maintaining a Underperform rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA Securities Upgrades Americold Realty Trust (COLD) to Neutral
- Scorpio Tankers (STNG) PT Lowered to $76 at Morgan Stanley
- Marvell (MRVL) PT Raised to $225 at TD Cowen
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
